VERTEX PHARMACEUTICALS INC / MA EPS (Diluted) 2008-2025 | VRTX
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is VERTEX PHARMACEUTICALS INC / MA's current eps (diluted)?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual eps (diluted) for 2025 was $15.32, a 836.54% increase from 2024. VERTEX PHARMACEUTICALS INC / MA eps (diluted) for the quarter ending September 30, 2025 was $4.20.
What was VERTEX PHARMACEUTICALS INC / MA's eps (diluted) in 2024?
VERTEX PHARMACEUTICALS INC / MA annual eps (diluted) for 2024 was $-2.08, a 114.97% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's eps (diluted) in 2023?
VERTEX PHARMACEUTICALS INC / MA annual eps (diluted) for 2023 was $13.89, a 8.35% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year eps (diluted) CAGR?
VERTEX PHARMACEUTICALS INC / MA eps (diluted) grew at a compound annual growth rate (CAGR) of 8.29% from FY2020 to FY2025, going from $10.29 to $15.32 over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $15.32 | +836.5% | 10-K |
| FY2024 | $-2.08 | -115.0% | 10-K |
| FY2023 | $13.89 | +8.3% | 10-K |
| FY2022 | $12.82 | +42.3% | 10-K |
| FY2021 | $9.01 | -12.4% | 10-K |
| FY2020 | $10.29 | +128.2% | 10-K |
| FY2019 | $4.51 | -44.3% | 10-K |
| FY2018 | $8.09 | +677.9% | 10-K |
| FY2017 | $1.04 | +326.1% | 10-K |
| FY2016 | $-0.46 | +80.1% | 10-K |
| FY2015 | $-2.31 | +26.4% | 10-K |
| FY2014 | $-3.14 | -58.6% | 10-K |
| FY2013 | $-1.98 | -296.0% | 10-K |
| FY2012 | $-0.50 | -457.1% | 10-K |
| FY2011 | $0.14 | +103.7% | 10-K |
| FY2010 | $-3.77 | -1.6% | 10-K |
| FY2009 | $-3.71 | -13.5% | 10-K |
| FY2008 | $-3.27 | - | 10-K |